# Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate

> **NCT03886441** · PHASE2 · UNKNOWN · sponsor: **Tongji University** · enrollment: 194 (estimated)

## Conditions studied

- Locally Advanced Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Beclomethasone propionate

## Key facts

- **NCT ID:** NCT03886441
- **Lead sponsor:** Tongji University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2019-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03886441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03886441, "Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03886441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
